Cardiovascular Science - Journal

<!DOCTYPE html> <html class="no-js" lang="en"> <head> <meta charset="utf-8" /> <meta http-equiv="x-ua-compatible" content="ie=edge" /> <title>Cardiovascular Science - Journal - SCIEPublish</title> <meta name="keywords" content="SCIE Publishing, SCIEPublish, open access, fast publication" /> <meta name="description" content="SCIEPublish is an international open-access journal publishing service provider run by SCIE Publishing Limited, dedicated to supporting and inspiring scientists or institutions/societies who aspire to publish high-quality journals." /> <meta name="viewport" content="width=device-width,user-scalable=no,initial-scale=1.0,maximum-scale=1.0,minimum-scale=1.0"> <link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" /> <link rel="stylesheet" href="/static/css/bootstrap.css" /> <link rel="stylesheet" href="/static/font/bootstrap-icons.css"> <link rel="stylesheet" href="/static/css/lightbox.css" /> <link rel="stylesheet" href="/static/css/theme.css?74" /> <link rel="stylesheet" href="/static/css/common.css?90" /> <link rel="stylesheet" href="/static/css/ckeditorStyle.css?2" /> <link rel="stylesheet" href="/static/css/select-mania.min.css" /> <script src="/static/js/jquery-3.7.1.min.js"></script> <script src="/static/js/lightbox.js"></script> <script src="/static/js/bootstrap.bundle.min.js"></script> <script src="/static/js/select-mania.js"></script> </head> <body class="header-no-fixed"> <header> <nav class="navbar navbar-expand-lg navbar-light my-body-container"> <div class="navbar-left"> <a href="/" class="uk-navbar-item" alt="Back to the homepage"> <svg xmlns="http://www.w3.org/2000/svg" class="navbar-logo" xml:space="preserve" version="1.0" viewBox="0 0 5.08 1.933"> <path d="M1.021 1.245a.29.29 0 0 1-.211-.054l-.027-.023-.003-.003.056-.066.003.004a.3.3 0 0 0 .043.033.2.2 0 0 0 .128.027l.024-.007.019-.01a.07.07 0 0 0 .022-.032.1.1 0 0 0 0-.036l-.004-.014a.1.1 0 0 0-.016-.02.1.1 0 0 0-.027-.017L.994 1.01.919.98a.3.3 0 0 1-.076-.05.14.14 0 0 1-.034-.067.2.2 0 0 1 0-.06.13.13 0 0 1 .027-.056.2.2 0 0 1 .049-.041A.2.2 0 0 1 .95.683a.3.3 0 0 1 .07-.001.2.2 0 0 1 .06.017.3.3 0 0 1 .075.05l.003.003-.05.061L1.103.81a.2.2 0 0 0-.053-.034.2.2 0 0 0-.063-.013.1.1 0 0 0-.046.008L.925.78a.06.06 0 0 0-.023.047l.001.015.006.012a.1.1 0 0 0 .018.02.1.1 0 0 0 .027.017L.97.899l.016.006.074.032a.3.3 0 0 1 .058.033.14.14 0 0 1 .051.08.2.2 0 0 1 0 .07.15.15 0 0 1-.048.081.2.2 0 0 1-.062.035zm.527-.002a.24.24 0 0 1-.1 0 .23.23 0 0 1-.125-.069.2.2 0 0 1-.051-.089.3.3 0 0 1-.019-.119.4.4 0 0 1 .02-.12.3.3 0 0 1 .052-.09.23.23 0 0 1 .176-.076.3.3 0 0 1 .064.01.3.3 0 0 1 .053.025.2.2 0 0 1 .04.034l.002.003-.052.061L1.605.81A.2.2 0 0 0 1.56.776a.2.2 0 0 0-.037-.012.15.15 0 0 0-.082.013.13.13 0 0 0-.049.039l-.018.029a.2.2 0 0 0-.022.073.4.4 0 0 0 .002.104.2.2 0 0 0 .014.05.2.2 0 0 0 .023.04.14.14 0 0 0 .066.047.15.15 0 0 0 .107-.009l.028-.017.025-.023.003-.004.051.06-.002.003a.3.3 0 0 1-.076.059.2.2 0 0 1-.045.015m.314-.004h-.09V.69h.095v.549zm.485 0h-.331V.69h.328v.08H2.11v.141h.198v.082H2.11v.165h.242v.08zm.215 0h-.09V.69h.169a.4.4 0 0 1 .083.008L2.76.71l.031.016a.13.13 0 0 1 .044.053q.009.015.012.036a.22.22 0 0 1-.012.121l-.018.03a.176.176 0 0 1-.09.057.3.3 0 0 1-.084.011h-.076v.205zm.005-.472v.19h.068a.2.2 0 0 0 .056-.006.1.1 0 0 0 .038-.018.1.1 0 0 0 .022-.031.1.1 0 0 0 .007-.045l-.003-.03a.07.07 0 0 0-.028-.04L2.703.776 2.671.769 2.633.767zm.539.48a.2.2 0 0 1-.067-.003.1.1 0 0 1-.075-.07.3.3 0 0 1-.013-.09V.827h.093v.248a.3.3 0 0 0 .007.055l.008.017.012.012.016.007.02.002a.1.1 0 0 0 .033-.006.1.1 0 0 0 .03-.019.2.2 0 0 0 .03-.032V.826h.093v.413h-.078l-.006-.057a.2.2 0 0 1-.078.057zm.548-.002-.034.003-.03-.003-.029-.01A.2.2 0 0 1 3.51 1.2l-.007.039h-.075V.645h.093q0 .11-.002.219l.01-.008A.2.2 0 0 1 3.59.823a.2.2 0 0 1 .043-.007.2.2 0 0 1 .07.015.15.15 0 0 1 .07.074.2.2 0 0 1 .022.076.4.4 0 0 1 0 .095.3.3 0 0 1-.029.082.2.2 0 0 1-.079.075zm-.07-.077a.1.1 0 0 0 .046-.002.1.1 0 0 0 .043-.032l.015-.028a.2.2 0 0 0 .01-.036.3.3 0 0 0-.006-.114A.1.1 0 0 0 3.68.93.07.07 0 0 0 3.64.9.1.1 0 0 0 3.59.899l-.023.008-.023.015-.023.02v.193a.2.2 0 0 0 .043.027zm.424.08h-.015a.1.1 0 0 1-.051-.013l-.017-.016-.011-.022-.007-.026-.002-.031V.645h.093v.5L4 1.16l.003.004.003.003.008.002h.008l.005-.001h.004l.013.071-.004.002-.009.002zm.22-.01H4.14V.827h.093v.413zm-.026-.48L4.187.76q-.009 0-.016-.002L4.157.753a.05.05 0 0 1-.02-.02.1.1 0 0 1-.008-.027L4.13.69a.05.05 0 0 1 .027-.032L4.17.653a.07.07 0 0 1 .045.005.05.05 0 0 1 .03.048.1.1 0 0 1-.009.028.1.1 0 0 1-.02.019zm.315.488a.25.25 0 0 1-.19-.054l-.004-.003.045-.062.004.003a.3.3 0 0 0 .053.034.13.13 0 0 0 .058.012l.022-.002.016-.005.013-.008.009-.01a.05.05 0 0 0 .007-.025q0-.006-.002-.012l-.005-.01-.008-.009-.011-.008-.028-.014-.016-.006-.017-.007a.4.4 0 0 1-.079-.041.1.1 0 0 1-.028-.034L4.348.964 4.345.939a.12.12 0 0 1 .023-.07.1.1 0 0 1 .038-.033A.2.2 0 0 1 4.46.82a.2.2 0 0 1 .13.022l.037.024.003.003-.045.059-.003-.003A.2.2 0 0 0 4.54.9a.1.1 0 0 0-.065-.008.1.1 0 0 0-.027.012l-.007.01a.04.04 0 0 0-.007.022q0 .006.002.01l.005.01a.1.1 0 0 0 .017.015l.027.013.016.006.016.006.063.028.019.013a.1.1 0 0 1 .029.035l.008.023a.13.13 0 0 1-.008.077.1.1 0 0 1-.03.04.14.14 0 0 1-.05.027zm.307-.007h-.088V.645h.092q0 .115-.002.229a.3.3 0 0 1 .05-.038.2.2 0 0 1 .048-.017.2.2 0 0 1 .068.002.1.1 0 0 1 .057.038q.01.014.018.033A.314.314 0 0 1 5.08.98v.258h-.093V.99L4.985.96 4.98.936 4.97.92 4.96.907 4.943.9a.1.1 0 0 0-.037 0 .1.1 0 0 0-.03.011l-.016.01-.032.03v.288z" /> <path d="M1.844 1.377a.97.97 0 0 1-.878.563A.963.963 0 0 1 0 .974.964.964 0 0 1 .966.007a.96.96 0 0 1 .865.536l-.048.024A.92.92 0 0 0 .966.062a.91.91 0 0 0-.912.912.91.91 0 0 0 .912.912.91.91 0 0 0 .83-.532z" class="logo-circle" /> </svg> </a> </div> <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation"> <div class="btn-menu"> <span></span> <span></span> <span></span> </div> </button> <div class="collapse navbar-collapse" id="navbarSupportedContent"> <div class="nav-form-search"> <form class="form-search" method="get" action="/index/search/index.html"> <input class="search-input" type="text" name="search" placeholder="What are you looking for?" autofocus /> <button type="submit">Search</button> </form> </div> <ul class="navbar-nav uk-navbar-nav"> <li class="nav-item "> <a class="nav-link" href="/">Home</a> </li> <li class="nav-item "> <a class="nav-link" href="/About_SCIEPublish">About</a> </li> <li class="nav-item uk-active"> <a class="nav-link" href="/index/journals/index">Journals</a> </li> <li class="nav-item "> <a class="nav-link" href="/news/list">News</a> </li> </ul> <a class="js-navbar-toggle sc-icon-button sc-transition" title="Search" href="#"> <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" fill="currentColor" class="bi bi-search" viewBox="0 0 16 16"> <path d="M11.742 10.344a6.5 6.5 0 1 0-1.397 1.398h-.001c.03.04.062.078.098.115l3.85 3.85a1 1 0 0 0 1.415-1.414l-3.85-3.85a1.007 1.007 0 0 0-.115-.1zM12 6.5a5.5 5.5 0 1 1-11 0 5.5 5.5 0 0 1 11 0z"/> </svg> <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" fill="currentColor" class="bi bi-x-lg" viewBox="0 0 16 16"> <path d="M2.146 2.854a.5.5 0 1 1 .708-.708L8 7.293l5.146-5.147a.5.5 0 0 1 .708.708L8.707 8l5.147 5.146a.5.5 0 0 1-.708.708L8 8.707l-5.146 5.147a.5.5 0 0 1-.708-.708L7.293 8 2.146 2.854Z"/> </svg> </a> <a class="uk-button sc-transition" href="/my/submitting">Publish with us</a> <a class="text-login" title="Sign in" href="/index/user/login.html"> Sign in </a> </div> </nav> </header> <section class="book-item"> <div class="my-body-container"> <div class="d-flex align-items-start pb-1 pt-3"> <div class="articles-img align-self-start"> <div class="journals-cover article-img mb-2"> <a href="/uploads/2024/05/28/1716874725pj60.jpg" data-lightbox="image-4" data-title=""> <img src="/uploads/2024/05/28/1716874725pj60.jpg" alt="Cardiovascular Science-logo"> </a> </div> </div> <div class="flex-grow-1 pl-5 pb-2"> <div class="d-flex justify-content-center"> <div class="left-title"> <h1 class="d-flex justify-content-between align-items-center"> Cardiovascular Science <a class="orange-color mb-0" href="/journals/cvs/apc"> <img src="/style/image/open_access.png"> Open Access </a> </h1> <div class="d-flex"> <div class="flex-grow-1"> <div class="right-title d-flex align-items-center"> <p class="text-right mr-2">ISSN: 3006-3906 <span>(Online)</span></p> <p class="text-right mr-2">3006-3892 <span>(Print)</span></p> <p class="text-right mr-2"></p> </div> <div class="item-text"> <strong><em>Cardiovascular Science</em></strong> is a peer-reviewed, open access international journal that publishes original research highlights, research articles and review articles on all aspects of cardiovascular basic and clinical research. </div> </div> </div> </div> </div> </div> </div> </div> </section> <section class="mb-3 book-column"> <div class="my-body-container padding0"> <div class="book-item-fixed default-hide pt-2 pb-2"> <div class="d-flex align-items-center"> <div class="left-logo mr-3"> <a href="/" alt="Back to the homepage"> <svg xmlns="http://www.w3.org/2000/svg" class="navbar-logo" xml:space="preserve" version="1.0" viewBox="0 0 5.08 1.933"> <path d="M1.021 1.245a.29.29 0 0 1-.211-.054l-.027-.023-.003-.003.056-.066.003.004a.3.3 0 0 0 .043.033.2.2 0 0 0 .128.027l.024-.007.019-.01a.07.07 0 0 0 .022-.032.1.1 0 0 0 0-.036l-.004-.014a.1.1 0 0 0-.016-.02.1.1 0 0 0-.027-.017L.994 1.01.919.98a.3.3 0 0 1-.076-.05.14.14 0 0 1-.034-.067.2.2 0 0 1 0-.06.13.13 0 0 1 .027-.056.2.2 0 0 1 .049-.041A.2.2 0 0 1 .95.683a.3.3 0 0 1 .07-.001.2.2 0 0 1 .06.017.3.3 0 0 1 .075.05l.003.003-.05.061L1.103.81a.2.2 0 0 0-.053-.034.2.2 0 0 0-.063-.013.1.1 0 0 0-.046.008L.925.78a.06.06 0 0 0-.023.047l.001.015.006.012a.1.1 0 0 0 .018.02.1.1 0 0 0 .027.017L.97.899l.016.006.074.032a.3.3 0 0 1 .058.033.14.14 0 0 1 .051.08.2.2 0 0 1 0 .07.15.15 0 0 1-.048.081.2.2 0 0 1-.062.035zm.527-.002a.24.24 0 0 1-.1 0 .23.23 0 0 1-.125-.069.2.2 0 0 1-.051-.089.3.3 0 0 1-.019-.119.4.4 0 0 1 .02-.12.3.3 0 0 1 .052-.09.23.23 0 0 1 .176-.076.3.3 0 0 1 .064.01.3.3 0 0 1 .053.025.2.2 0 0 1 .04.034l.002.003-.052.061L1.605.81A.2.2 0 0 0 1.56.776a.2.2 0 0 0-.037-.012.15.15 0 0 0-.082.013.13.13 0 0 0-.049.039l-.018.029a.2.2 0 0 0-.022.073.4.4 0 0 0 .002.104.2.2 0 0 0 .014.05.2.2 0 0 0 .023.04.14.14 0 0 0 .066.047.15.15 0 0 0 .107-.009l.028-.017.025-.023.003-.004.051.06-.002.003a.3.3 0 0 1-.076.059.2.2 0 0 1-.045.015m.314-.004h-.09V.69h.095v.549zm.485 0h-.331V.69h.328v.08H2.11v.141h.198v.082H2.11v.165h.242v.08zm.215 0h-.09V.69h.169a.4.4 0 0 1 .083.008L2.76.71l.031.016a.13.13 0 0 1 .044.053q.009.015.012.036a.22.22 0 0 1-.012.121l-.018.03a.176.176 0 0 1-.09.057.3.3 0 0 1-.084.011h-.076v.205zm.005-.472v.19h.068a.2.2 0 0 0 .056-.006.1.1 0 0 0 .038-.018.1.1 0 0 0 .022-.031.1.1 0 0 0 .007-.045l-.003-.03a.07.07 0 0 0-.028-.04L2.703.776 2.671.769 2.633.767zm.539.48a.2.2 0 0 1-.067-.003.1.1 0 0 1-.075-.07.3.3 0 0 1-.013-.09V.827h.093v.248a.3.3 0 0 0 .007.055l.008.017.012.012.016.007.02.002a.1.1 0 0 0 .033-.006.1.1 0 0 0 .03-.019.2.2 0 0 0 .03-.032V.826h.093v.413h-.078l-.006-.057a.2.2 0 0 1-.078.057zm.548-.002-.034.003-.03-.003-.029-.01A.2.2 0 0 1 3.51 1.2l-.007.039h-.075V.645h.093q0 .11-.002.219l.01-.008A.2.2 0 0 1 3.59.823a.2.2 0 0 1 .043-.007.2.2 0 0 1 .07.015.15.15 0 0 1 .07.074.2.2 0 0 1 .022.076.4.4 0 0 1 0 .095.3.3 0 0 1-.029.082.2.2 0 0 1-.079.075zm-.07-.077a.1.1 0 0 0 .046-.002.1.1 0 0 0 .043-.032l.015-.028a.2.2 0 0 0 .01-.036.3.3 0 0 0-.006-.114A.1.1 0 0 0 3.68.93.07.07 0 0 0 3.64.9.1.1 0 0 0 3.59.899l-.023.008-.023.015-.023.02v.193a.2.2 0 0 0 .043.027zm.424.08h-.015a.1.1 0 0 1-.051-.013l-.017-.016-.011-.022-.007-.026-.002-.031V.645h.093v.5L4 1.16l.003.004.003.003.008.002h.008l.005-.001h.004l.013.071-.004.002-.009.002zm.22-.01H4.14V.827h.093v.413zm-.026-.48L4.187.76q-.009 0-.016-.002L4.157.753a.05.05 0 0 1-.02-.02.1.1 0 0 1-.008-.027L4.13.69a.05.05 0 0 1 .027-.032L4.17.653a.07.07 0 0 1 .045.005.05.05 0 0 1 .03.048.1.1 0 0 1-.009.028.1.1 0 0 1-.02.019zm.315.488a.25.25 0 0 1-.19-.054l-.004-.003.045-.062.004.003a.3.3 0 0 0 .053.034.13.13 0 0 0 .058.012l.022-.002.016-.005.013-.008.009-.01a.05.05 0 0 0 .007-.025q0-.006-.002-.012l-.005-.01-.008-.009-.011-.008-.028-.014-.016-.006-.017-.007a.4.4 0 0 1-.079-.041.1.1 0 0 1-.028-.034L4.348.964 4.345.939a.12.12 0 0 1 .023-.07.1.1 0 0 1 .038-.033A.2.2 0 0 1 4.46.82a.2.2 0 0 1 .13.022l.037.024.003.003-.045.059-.003-.003A.2.2 0 0 0 4.54.9a.1.1 0 0 0-.065-.008.1.1 0 0 0-.027.012l-.007.01a.04.04 0 0 0-.007.022q0 .006.002.01l.005.01a.1.1 0 0 0 .017.015l.027.013.016.006.016.006.063.028.019.013a.1.1 0 0 1 .029.035l.008.023a.13.13 0 0 1-.008.077.1.1 0 0 1-.03.04.14.14 0 0 1-.05.027zm.307-.007h-.088V.645h.092q0 .115-.002.229a.3.3 0 0 1 .05-.038.2.2 0 0 1 .048-.017.2.2 0 0 1 .068.002.1.1 0 0 1 .057.038q.01.014.018.033A.314.314 0 0 1 5.08.98v.258h-.093V.99L4.985.96 4.98.936 4.97.92 4.96.907 4.943.9a.1.1 0 0 0-.037 0 .1.1 0 0 0-.03.011l-.016.01-.032.03v.288z" /> <path d="M1.844 1.377a.97.97 0 0 1-.878.563A.963.963 0 0 1 0 .974.964.964 0 0 1 .966.007a.96.96 0 0 1 .865.536l-.048.024A.92.92 0 0 0 .966.062a.91.91 0 0 0-.912.912.91.91 0 0 0 .912.912.91.91 0 0 0 .83-.532z" class="logo-circle" /> </svg> </a> </div> <div class="journals-cover mr-3"><a href="/journals/cvs"> <img src="/uploads/2024/05/28/1716874725pj60.jpg" alt="Cardiovascular Science-logo"></a> </div> <h2 class="flex-grow-1"><a href="/journals/cvs">Cardiovascular Science</a></h2> </div> </div> <div class="column-bottom d-flex align-self-stretch"> <div class="column-left"> <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarToggleExternalContent" aria-controls="navbarToggleExternalContent" aria-expanded="false" aria-label="Toggle navigation"> <div class="d-flex align-items-center justify-content-center"> <div class="btn-menu"> <span></span> <span></span> <span></span> </div> <div class="btn-menu-text">Menu</div> </div> </button> <div class="collapse" id="navbarToggleExternalContent"> <div class="row ml-0 mr-0"> <div class="dropdown line-dropdown col pl-0 pr-0"> <a class="btn dropdown-toggle" href="javescipt:void(0);" role="button" data-toggle="dropdown" aria-expanded="false"> About </a> <div class="dropdown-menu rounded-0 mt-0"> <a class="dropdown-item" href="/journals/cvs/about">Aim & Scope</a> <a class="dropdown-item" href="/journals/cvs/editors">Editorial Board</a> <a class="dropdown-item" href="/journals/cvs/indexing">Indexing & Archiving</a> <a class="dropdown-item" href="/journals/cvs/article_processing_charge">Article Processing Charge</a> <a class="dropdown-item" href="/journals/cvs/news">News</a> <a class="dropdown-item" href="/Open_Access_Policy">Open Access Policy</a>  <a class="dropdown-item" href="/Editorial_Policy">Editorial Policy</a>  <a class="dropdown-item" href="/journals/cvs/editorial_office">Editorial Office</a> </div> </div> <div class="dropdown line-dropdown col pl-0 pr-0"> <a class="btn dropdown-toggle" href="#" role="button" data-toggle="dropdown" aria-expanded="false"> Articles </a> <div class="dropdown-menu rounded-0 mt-0"> <a class="dropdown-item" href="/journals/cvs/roll/1/1">Current lssue</a>    <a class="dropdown-item" href="/journals/cvs/issues">Issue Archives</a> </div> </div> </div> </div> </div> <form class="form-search flex-grow-1 d-flex" method="get" action=""> <input type="hidden" name="issues" value="0"> <input id="search-input" class="search-input flex-grow-1 flex-shrink-1" type="text" name="search" placeholder="Search in this journal" value="" autofocus /> <div class="s-btn-close d-flex align-items-center" title="Empty search box"> <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" fill="currentColor" class="bi bi-x-lg" viewBox="0 0 16 16"> <path d="M2.146 2.854a.5.5 0 1 1 .708-.708L8 7.293l5.146-5.147a.5.5 0 0 1 .708.708L8.707 8l5.147 5.146a.5.5 0 0 1-.708.708L8 8.707l-5.146 5.147a.5.5 0 0 1-.708-.708L7.293 8 2.146 2.854Z"/> </svg> </div> <button type="submit"> <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" fill="currentColor" class="bi bi-search" viewBox="0 0 16 16"> <path d="M11.742 10.344a6.5 6.5 0 1 0-1.397 1.398h-.001c.03.04.062.078.098.115l3.85 3.85a1 1 0 0 0 1.415-1.414l-3.85-3.85a1.007 1.007 0 0 0-.115-.1zM12 6.5a5.5 5.5 0 1 1-11 0 5.5 5.5 0 0 1 11 0z"/> </svg> </button> </form> <div class="column-right-title d-flex"> <a class="d-flex align-items-center" href="/journals/cvs/instructions"> Guide for Authors <svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" fill="currentColor" class="bi bi-chevron-double-right" viewBox="0 0 16 16"> <path fill-rule="evenodd" d="M3.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L9.293 8 3.646 2.354a.5.5 0 0 1 0-.708z"></path> <path fill-rule="evenodd" d="M7.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L13.293 8 7.646 2.354a.5.5 0 0 1 0-.708z"></path> </svg> </a> <a class="d-flex align-items-center" href="/my/submitting/journal/53"> Submit to CVS <svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" fill="currentColor" class="bi bi-chevron-double-right" viewBox="0 0 16 16"> <path fill-rule="evenodd" d="M3.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L9.293 8 3.646 2.354a.5.5 0 0 1 0-.708z"></path> <path fill-rule="evenodd" d="M7.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L13.293 8 7.646 2.354a.5.5 0 0 1 0-.708z"></path> </svg> </a> </div> </div> </div> </section> <section class="mb-1 avatar-news-item"> <div class="my-body-container"> <div class="section-heading border-top-0"> <h3 class="section-title"> Editors-in-Chief </h3> </div> <ul class="row mt-3"> <li class="col pb-2 mb-2"> <div class="d-flex align-items-center height100"> <div class="avatar-container"> <a class="avatar-img" href="/journals/cvs/editors"> <img src="/uploads/2023/10/23/1698048980ru4r.png" class="avatar img-thumbnail"> </a> </div> <div class="flex-grow-1 ml-3"> <h5>Prof. Dr. Cheng Zhang</h5> <p>Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, China</p> </div> </div> </li> <li class="col pb-2 mb-2"> <div class="d-flex align-items-center height100"> <div class="avatar-container"> <a class="avatar-img" href="/journals/cvs/editors"> <img src="/uploads/2023/11/21/170055593166t3.png" class="avatar img-thumbnail"> </a> </div> <div class="flex-grow-1 ml-3"> <h5>Prof. Dr. Yihai Cao</h5> <p>Karolinska Institutet, 171 77 Stockholm, Sweden</p> </div> </div> </li> </ul> </div> </section> <section class="articles-list1 mb-3"> <div class="my-body-container padding0"> <div class="section-heading"> <h3 class="section-title"> Articles <span>(7)</span> <a class="right" href="/journals/cvs/articles" target="_blank"> All articles <svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" fill="currentColor" class="bi bi-chevron-double-right" viewBox="0 0 16 16"> <path fill-rule="evenodd" d="M3.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L9.293 8 3.646 2.354a.5.5 0 0 1 0-.708z"/> <path fill-rule="evenodd" d="M7.646 1.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1 0 .708l-6 6a.5.5 0 0 1-.708-.708L13.293 8 7.646 2.354a.5.5 0 0 1 0-.708z"/> </svg> </a> </h3> </div> <ul class="nav nav-tabs mt-2"> <li class="nav-item"><a class="nav-link active" id="all-tab" data-toggle="tab" href="#id-all">Latest published</a></li> <li class="nav-item"><a class="nav-link" id="downloaded-tab" data-toggle="tab" href="#id-downloaded">Most downloaded</a></li> <li class="nav-item"><a class="nav-link" id="popular-tab" data-toggle="tab" href="#id-popular" role="tab">Most popular</a></li> </ul> <div class="tab-content" id="myTabContent"> <div class="tab-pane fade show active" id="id-all"> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Research Highlight</h4> <span>27 September 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/289">The Response of Vascular Endothelial Cells Post-Stroke and Its Role in Accelerating Atherosclerosis Progression</a> </h3> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=KanLi" target="_blank"> Kan Li </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=ChenghuGuo" target="_blank"> Chenghu Guo </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=ShutingYu" target="_blank"> Shuting Yu </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=ZekunXu" target="_blank"> Zekun Xu </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=MengZhang" target="_blank"> Meng Zhang* </a> </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/09/27/50b13f90226c77bc88f0ef948826b1f4.png" data-lightbox="image-1" data-title=""><img src="/uploads/2024/09/27/50b13f90226c77bc88f0ef948826b1f4.png" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Research Highlight</h4> <span>19 September 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/282">Tumour Necrosis Factor Receptor-Associated Protein 1 (TRAP1): A Pivotal Regulator of Smooth Muscle Cell Senescence and Atherosclerosis through Metabolic Reprogramming</a> </h3> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=ChangMa" target="_blank"> Chang Ma </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=WenchengZhang" target="_blank"> Wencheng Zhang* </a> </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/09/19/100291a267a701bde11d3cf5cb0f6fc7.jpg" data-lightbox="image-2" data-title=""><img src="/uploads/2024/09/19/100291a267a701bde11d3cf5cb0f6fc7.jpg" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Article</h4> <span>02 September 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/268">Risk Factors for Adverse Outcomes Following Surgical Repair of Simple Coarctation in Early Infancy: A Ten-Year Single Center Review</a> </h3> <p class="article-abseract clamp">Background: Coarctation of the aorta is a frequently diagnosed congenital heart defect and often requires surgical repair in early infancy. Infants born with this condition remain at risk for post-operative morbidity and reintervention within the first year of life. Methods: A single-center, retrospective chart review was performed. The protocol was approved by the Institutional Review Board (IRB-21-156, 14 August 2021). A 10-year review from January 2010 to December 2020 identified all children diagnosed with coarctation of the aorta or arch hypoplasia; without any associated major congenital cardiac pathology (i.e., simple coarctation). Reintervention-free-survival at one year for all infants who underwent surgical repair was assessed. Patient characteristics for those who did and did not experience significant adverse event (SAE) in the postoperative period were obtained and compared. Results: A total of 105 patients diagnosed with isolated coarctation of the aorta or arch hypoplasia and who underwent surgical repair were identified. Of these, 11 patients (10%) experienced a SAE (i.e., vocal cord palsy, diaphragm palsy, chylothorax, stroke/neurological complication, need for reintubation or tracheostomy, necrotizing enterocolitis, major bleeding or thrombotic vascular complication, or reintervention) in the post-operative period. Patients who experienced a SAE were more likely to have a prenatal diagnosis of coarctation of the aorta (<i>p</i> = 0.03), a known genetic anomaly (<i>p</i> = 0.0001), or had undergone a median sternotomy approach/complex arch repair (i.e., requiring patching of the aorta) (<i>p</i> = 0.0001). Genetic anomaly (mainly Turner syndrome) was the only independent predictor of SAE in multivariate analysis (OR = 6.7) Follow up data at one year was available for 79 patients, with only 6 patients requiring reintervention before 1 year of age. Conclusions: Overall, infants who undergo surgical repair of simple coarctation of aorta have an excellent chance of reintervention-free-survival at one year post intervention. Those with a known genetic anomaly or requiring median sternotomy approach appear to have a higher risk for a SAE in the postoperative period.</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=ChristinaL.Benjamin" target="_blank"> Christina L. Benjamin* </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=RooseveltBryant III" target="_blank"> Roosevelt Bryant III </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=DeeptiP.Bhat" target="_blank"> Deepti P. Bhat </a> </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/09/02/cb93cb1083b6d5a0b0ee5b5f772282bc.png" data-lightbox="image-3" data-title=""><img src="/uploads/2024/09/02/cb93cb1083b6d5a0b0ee5b5f772282bc.png" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Review</h4> <span>27 August 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/259">A Novel Comprehensive Program Combining Optimal Medical Treatment with Lifestyle Modification for Type 2 Diabetes</a> </h3> <p class="article-abseract clamp">There are more and more individuals with type 2 diabetes (T2D) in the globe. It’s a huge burden of public health and a great challenge in clinical due to a high linkage with atherosclerosis, cardiovascular disease (CVD), stroke, and cancer. However, little is known about a comprehensive program of management and self-management of T2D. This article introduces briefly the current status in T2D and an updated classical standardized comprehensive program which combines optimal medical treatment (OMT) (the glucagon-like peptide-1 receptor agonists, the sodium-glucose cotransporter 2 inhibitors, and the ultralong-acting, once-daily basal insulin) with lifestyle modification, that is, intervention of RT-ABCDEFG (iRT-ABCDEFG) for control and prevention of T2D, and discusses its advantages and prospects. As an effective comprehensive program and strategy for interventions of diabetes, this program can be used as a reversible, right, and routine treatment. Several pivotal goals including less major adverse cardiocerebrovascular events (MACCE) and diabetic complications, less medical costs, longer life expectancy, lower morbidity and mortality, and higher quality of life, will be realized by consistently practicing this program due to early diagnosis, OMT, and lifestyle modification for overall prevention. All in all, since T2D highly links to CVD and cancer, as well as other MACCE, this novel iRT-ABCDEFG program is very helpful in comprehensive management and self-management of T2D and worth recommending for further application and health care of T2D due to better clinical efficacy and cost-effective relationship.</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=ChunsongHu" target="_blank"> Chunsong Hu* </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=TengizTkebuchava" target="_blank"> Tengiz Tkebuchava </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=QinghuaWu" target="_blank"> Qinghua Wu </a> </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/08/27/eb3b12510218a956c078005b0cca7cc3.jpg" data-lightbox="image-4" data-title=""><img src="/uploads/2024/08/27/eb3b12510218a956c078005b0cca7cc3.jpg" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Article</h4> <span>09 August 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/246">Interstage Growth Failure May Adversely Affect Clinical Outcomes in Hypoplastic Left Heart Syndrome: Results from a Single Center Ten-Year Review</a> </h3> <p class="article-abseract clamp">Purpose: Infants with Hypoplastic left heart syndrome (HLHS) are particularly vulnerable during their interstage period which is the time between Stage 1 palliation (S1P) and Stage 2 palliation (S2P). Interstage Monitoring Program (IMP) was established to reduce mortality after discharge following S1P and consists of close monitoring of certain key parameters including hypoxia, growth failure and occurrence of major events. As somatic growth is a potentially modifiable determinant of interstage mortality, we aimed to study the incidence and risk factors of growth failure among infants followed by our IMP over the last 10 years. Methods: We included HLHS infants who were enrolled in institutional IMP following discharge after S1P from May 2009 to April 2019. Growth failure was defined as per the NPC-QIC criterion as failure to achieve target interstage weight of 20<b>–</b>30 g per day and risk factors for growth failure were explored. Results: A total of 87 patients were enrolled during the study period, of whom 72 (<i>n</i> = 83%) underwent S2P. About one third (23 patients) failed to achieve the target growth rate despite close monitoring through a robust IMP. Growth failure significantly delayed the time to more stable S2P circulation (median IS duration: 131 days vs 86 days, <i>p</i> = 0.002). Patients with growth failure had a significantly higher incidence of death/transplant prior to Stage 3 (Fontan) completion (39% vs 16%, <i>p</i> = 0.03). Interstage growth failure was significantly associated with a “Hybrid-type” of repair during S1P (<i>p</i> = 0.03); and with the need for opioids at discharge (<i>p</i> = 0.04). Conclusion: This study highlights that growth failure is common in HLHS patients, despite active intervention through an IMP program. These patients appear to have significantly worse transplant-free survival rates compared to their counterparts. Pre-interstage risk factors including use of opioids may need to be addressed to assist adequate somatic growth during interstage.</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=KaitlynBates" target="_blank"> Kaitlyn Bates </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=JosephNGraziano" target="_blank"> Joseph N Graziano </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=DeeptiPBhat" target="_blank"> Deepti P Bhat* </a> </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/08/09/71a29fc5e696b664269e5e9a3b896cd3.png" data-lightbox="image-5" data-title=""><img src="/uploads/2024/08/09/71a29fc5e696b664269e5e9a3b896cd3.png" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Case Report</h4> <span>11 June 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/207">Early Experience Using Implanted Hemodynamic Monitor (CardioMEMs) for Hemodynamic Assessment during Exercise in Pediatric Patients with Fontan Circulation</a> </h3> <p class="article-abseract clamp">Assessment of Fontan pressures during exercise has been previously challenging. We report our experience with 4 children, in whom implanted hemodynamic monitor was utilized to assess Fontan pressures during exercise. Data was used to modify treatment in one case. The device provided useful insight into exercise-related changes in Fontan patients.</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=ArashASabati" target="_blank"> Arash A Sabati* </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=BillChesney" target="_blank"> Bill Chesney </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=JakeMontchal" target="_blank"> Jake Montchal </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=DeeptiPBhat" target="_blank"> Deepti P Bhat </a> </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/06/11/a03e2b985d2b39fcac3beb65959664f3.jpg" data-lightbox="image-6" data-title=""><img src="/uploads/2024/06/11/a03e2b985d2b39fcac3beb65959664f3.jpg" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Editorial</h4> <span>25 January 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/121"><em>Cardiovascular Science</em>: A New Open-Access Journal to Share Your Research on Cardiovascular Diseases</a> </h3> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=ChengZhang" target="_blank"> Cheng Zhang* </a> </div> <div class="author-name"> <a href="https://scholar.google.com/scholar?q=YihaiCao" target="_blank"> Yihai Cao* </a> </div> </div> </div> </div> </div> <div class="tab-pane fade" id="id-downloaded"> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Editorial</h4> <span>25 January 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/121"><em>Cardiovascular Science</em>: A New Open-Access Journal to Share Your Research on Cardiovascular Diseases</a> </h3> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> ChengZhang </div> <div class="author-name"> YihaiCao </div> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Case Report</h4> <span>11 June 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/207">Early Experience Using Implanted Hemodynamic Monitor (CardioMEMs) for Hemodynamic Assessment during Exercise in Pediatric Patients with Fontan Circulation</a> </h3> <p class="article-abseract clamp">Assessment of Fontan pressures during exercise has been previously challenging. We report our experience with 4 children, in whom implanted hemodynamic monitor was utilized to assess Fontan pressures during exercise. Data was used to modify treatment in one case. The device provided useful insight into exercise-related changes in Fontan patients.</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> ArashASabati </div> <div class="author-name"> BillChesney </div> <div class="author-name"> JakeMontchal </div> <div class="author-name"> DeeptiPBhat </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/06/11/a03e2b985d2b39fcac3beb65959664f3.jpg" data-lightbox="image-2" data-title=""><img src="/uploads/2024/06/11/a03e2b985d2b39fcac3beb65959664f3.jpg" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Article</h4> <span>09 August 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/246">Interstage Growth Failure May Adversely Affect Clinical Outcomes in Hypoplastic Left Heart Syndrome: Results from a Single Center Ten-Year Review</a> </h3> <p class="article-abseract clamp">Purpose: Infants with Hypoplastic left heart syndrome (HLHS) are particularly vulnerable during their interstage period which is the time between Stage 1 palliation (S1P) and Stage 2 palliation (S2P). Interstage Monitoring Program (IMP) was established to reduce mortality after discharge following S1P and consists of close monitoring of certain key parameters including hypoxia, growth failure and occurrence of major events. As somatic growth is a potentially modifiable determinant of interstage mortality, we aimed to study the incidence and risk factors of growth failure among infants followed by our IMP over the last 10 years. Methods: We included HLHS infants who were enrolled in institutional IMP following discharge after S1P from May 2009 to April 2019. Growth failure was defined as per the NPC-QIC criterion as failure to achieve target interstage weight of 20<b>–</b>30 g per day and risk factors for growth failure were explored. Results: A total of 87 patients were enrolled during the study period, of whom 72 (<i>n</i> = 83%) underwent S2P. About one third (23 patients) failed to achieve the target growth rate despite close monitoring through a robust IMP. Growth failure significantly delayed the time to more stable S2P circulation (median IS duration: 131 days vs 86 days, <i>p</i> = 0.002). Patients with growth failure had a significantly higher incidence of death/transplant prior to Stage 3 (Fontan) completion (39% vs 16%, <i>p</i> = 0.03). Interstage growth failure was significantly associated with a “Hybrid-type” of repair during S1P (<i>p</i> = 0.03); and with the need for opioids at discharge (<i>p</i> = 0.04). Conclusion: This study highlights that growth failure is common in HLHS patients, despite active intervention through an IMP program. These patients appear to have significantly worse transplant-free survival rates compared to their counterparts. Pre-interstage risk factors including use of opioids may need to be addressed to assist adequate somatic growth during interstage.</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> KaitlynBates </div> <div class="author-name"> JosephNGraziano </div> <div class="author-name"> Deepti PBhat </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/08/09/71a29fc5e696b664269e5e9a3b896cd3.png" data-lightbox="image-3" data-title=""><img src="/uploads/2024/08/09/71a29fc5e696b664269e5e9a3b896cd3.png" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Review</h4> <span>27 August 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/259">A Novel Comprehensive Program Combining Optimal Medical Treatment with Lifestyle Modification for Type 2 Diabetes</a> </h3> <p class="article-abseract clamp">There are more and more individuals with type 2 diabetes (T2D) in the globe. It’s a huge burden of public health and a great challenge in clinical due to a high linkage with atherosclerosis, cardiovascular disease (CVD), stroke, and cancer. However, little is known about a comprehensive program of management and self-management of T2D. This article introduces briefly the current status in T2D and an updated classical standardized comprehensive program which combines optimal medical treatment (OMT) (the glucagon-like peptide-1 receptor agonists, the sodium-glucose cotransporter 2 inhibitors, and the ultralong-acting, once-daily basal insulin) with lifestyle modification, that is, intervention of RT-ABCDEFG (iRT-ABCDEFG) for control and prevention of T2D, and discusses its advantages and prospects. As an effective comprehensive program and strategy for interventions of diabetes, this program can be used as a reversible, right, and routine treatment. Several pivotal goals including less major adverse cardiocerebrovascular events (MACCE) and diabetic complications, less medical costs, longer life expectancy, lower morbidity and mortality, and higher quality of life, will be realized by consistently practicing this program due to early diagnosis, OMT, and lifestyle modification for overall prevention. All in all, since T2D highly links to CVD and cancer, as well as other MACCE, this novel iRT-ABCDEFG program is very helpful in comprehensive management and self-management of T2D and worth recommending for further application and health care of T2D due to better clinical efficacy and cost-effective relationship.</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> Chunsong Hu </div> <div class="author-name"> Tengiz Tkebuchava </div> <div class="author-name"> Qinghua Wu </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/08/27/eb3b12510218a956c078005b0cca7cc3.jpg" data-lightbox="image-4" data-title=""><img src="/uploads/2024/08/27/eb3b12510218a956c078005b0cca7cc3.jpg" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Research Highlight</h4> <span>27 September 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/289">The Response of Vascular Endothelial Cells Post-Stroke and Its Role in Accelerating Atherosclerosis Progression</a> </h3> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> KanLi </div> <div class="author-name"> ChenghuGuo </div> <div class="author-name"> ShutingYu </div> <div class="author-name"> ZekunXu </div> <div class="author-name"> MengZhang </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/09/27/50b13f90226c77bc88f0ef948826b1f4.png" data-lightbox="image-5" data-title=""><img src="/uploads/2024/09/27/50b13f90226c77bc88f0ef948826b1f4.png" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Article</h4> <span>02 September 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/268">Risk Factors for Adverse Outcomes Following Surgical Repair of Simple Coarctation in Early Infancy: A Ten-Year Single Center Review</a> </h3> <p class="article-abseract clamp">Background: Coarctation of the aorta is a frequently diagnosed congenital heart defect and often requires surgical repair in early infancy. Infants born with this condition remain at risk for post-operative morbidity and reintervention within the first year of life. Methods: A single-center, retrospective chart review was performed. The protocol was approved by the Institutional Review Board (IRB-21-156, 14 August 2021). A 10-year review from January 2010 to December 2020 identified all children diagnosed with coarctation of the aorta or arch hypoplasia; without any associated major congenital cardiac pathology (i.e., simple coarctation). Reintervention-free-survival at one year for all infants who underwent surgical repair was assessed. Patient characteristics for those who did and did not experience significant adverse event (SAE) in the postoperative period were obtained and compared. Results: A total of 105 patients diagnosed with isolated coarctation of the aorta or arch hypoplasia and who underwent surgical repair were identified. Of these, 11 patients (10%) experienced a SAE (i.e., vocal cord palsy, diaphragm palsy, chylothorax, stroke/neurological complication, need for reintubation or tracheostomy, necrotizing enterocolitis, major bleeding or thrombotic vascular complication, or reintervention) in the post-operative period. Patients who experienced a SAE were more likely to have a prenatal diagnosis of coarctation of the aorta (<i>p</i> = 0.03), a known genetic anomaly (<i>p</i> = 0.0001), or had undergone a median sternotomy approach/complex arch repair (i.e., requiring patching of the aorta) (<i>p</i> = 0.0001). Genetic anomaly (mainly Turner syndrome) was the only independent predictor of SAE in multivariate analysis (OR = 6.7) Follow up data at one year was available for 79 patients, with only 6 patients requiring reintervention before 1 year of age. Conclusions: Overall, infants who undergo surgical repair of simple coarctation of aorta have an excellent chance of reintervention-free-survival at one year post intervention. Those with a known genetic anomaly or requiring median sternotomy approach appear to have a higher risk for a SAE in the postoperative period.</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> ChristinaL.Benjamin </div> <div class="author-name"> RooseveltBryant III </div> <div class="author-name"> DeeptiP.Bhat </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/09/02/cb93cb1083b6d5a0b0ee5b5f772282bc.png" data-lightbox="image-6" data-title=""><img src="/uploads/2024/09/02/cb93cb1083b6d5a0b0ee5b5f772282bc.png" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Research Highlight</h4> <span>19 September 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/282">Tumour Necrosis Factor Receptor-Associated Protein 1 (TRAP1): A Pivotal Regulator of Smooth Muscle Cell Senescence and Atherosclerosis through Metabolic Reprogramming</a> </h3> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> Chang Ma </div> <div class="author-name"> WenchengZhang </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/09/19/100291a267a701bde11d3cf5cb0f6fc7.jpg" data-lightbox="image-7" data-title=""><img src="/uploads/2024/09/19/100291a267a701bde11d3cf5cb0f6fc7.jpg" class=""></a> </div> </div> </div> </div> <div class="tab-pane fade" id="id-popular"> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Editorial</h4> <span>25 January 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/121"><em>Cardiovascular Science</em>: A New Open-Access Journal to Share Your Research on Cardiovascular Diseases</a> </h3> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> ChengZhang </div> <div class="author-name"> YihaiCao </div> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Case Report</h4> <span>11 June 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/207">Early Experience Using Implanted Hemodynamic Monitor (CardioMEMs) for Hemodynamic Assessment during Exercise in Pediatric Patients with Fontan Circulation</a> </h3> <p class="article-abseract clamp"> Assessment of Fontan pressures during exercise has been previously challenging. We report our experience with 4 children, in whom implanted hemodynamic monitor was utilized to assess Fontan pressures during exercise. Data was used to modify treatment in one case. The device provided useful insight into exercise-related changes in Fontan patients.utf-8</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> ArashASabati </div> <div class="author-name"> BillChesney </div> <div class="author-name"> JakeMontchal </div> <div class="author-name"> DeeptiPBhat </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/06/11/a03e2b985d2b39fcac3beb65959664f3.jpg" data-lightbox="image-2" data-title=""><img src="/uploads/2024/06/11/a03e2b985d2b39fcac3beb65959664f3.jpg" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Review</h4> <span>27 August 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/259">A Novel Comprehensive Program Combining Optimal Medical Treatment with Lifestyle Modification for Type 2 Diabetes</a> </h3> <p class="article-abseract clamp"> There are more and more individuals with type 2 diabetes (T2D) in the globe. It’s a huge burden of public health and a great challenge in clinical due to a high linkage with atherosclerosis, cardiovascular disease (CVD), stroke, and cancer. However, little is known about a comprehensive program of management and self-management of T2D. This article introduces briefly the current status in T2D and an updated classical standardized comprehensive program which combines optimal medical treatment (OMT) (the glucagon-like peptide-1 receptor agonists, the sodium-glucose cotransporter 2 inhibitors, and the ultralong-acting, once-daily basal insulin) with lifestyle modification, that is, intervention of RT-ABCDEFG (iRT-ABCDEFG) for control and prevention of T2D, and discusses its advantages and prospects. As an effective comprehensive program and strategy for interventions of diabetes, this program can be used as a reversible, right, and routine treatment. Several pivotal goals including less major adverse cardiocerebrovascular events (MACCE) and diabetic complications, less medical costs, longer life expectancy, lower morbidity and mortality, and higher quality of life, will be realized by consistently practicing this program due to early diagnosis, OMT, and lifestyle modification for overall prevention. All in all, since T2D highly links to CVD and cancer, as well as other MACCE, this novel iRT-ABCDEFG program is very helpful in comprehensive management and self-management of T2D and worth recommending for further application and health care of T2D due to better clinical efficacy and cost-effective relationship.utf-8</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> Chunsong Hu </div> <div class="author-name"> Tengiz Tkebuchava </div> <div class="author-name"> Qinghua Wu </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/08/27/eb3b12510218a956c078005b0cca7cc3.jpg" data-lightbox="image-3" data-title=""><img src="/uploads/2024/08/27/eb3b12510218a956c078005b0cca7cc3.jpg" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Article</h4> <span>09 August 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/246">Interstage Growth Failure May Adversely Affect Clinical Outcomes in Hypoplastic Left Heart Syndrome: Results from a Single Center Ten-Year Review</a> </h3> <p class="article-abseract clamp"> Purpose: Infants with Hypoplastic left heart syndrome (HLHS) are particularly vulnerable during their interstage period which is the time between Stage 1 palliation (S1P) and Stage 2 palliation (S2P). Interstage Monitoring Program (IMP) was established to reduce mortality after discharge following S1P and consists of close monitoring of certain key parameters including hypoxia, growth failure and occurrence of major events. As somatic growth is a potentially modifiable determinant of interstage mortality, we aimed to study the incidence and risk factors of growth failure among infants followed by our IMP over the last 10 years. Methods: We included HLHS infants who were enrolled in institutional IMP following discharge after S1P from May 2009 to April 2019. Growth failure was defined as per the NPC-QIC criterion as failure to achieve target interstage weight of 20<b>–</b>30 g per day and risk factors for growth failure were explored. Results: A total of 87 patients were enrolled during the study period, of whom 72 (<i>n</i> = 83%) underwent S2P. About one third (23 patients) failed to achieve the target growth rate despite close monitoring through a robust IMP. Growth failure significantly delayed the time to more stable S2P circulation (median IS duration: 131 days vs 86 days, <i>p</i> = 0.002). Patients with growth failure had a significantly higher incidence of death/transplant prior to Stage 3 (Fontan) completion (39% vs 16%, <i>p</i> = 0.03). Interstage growth failure was significantly associated with a “Hybrid-type” of repair during S1P (<i>p</i> = 0.03); and with the need for opioids at discharge (<i>p</i> = 0.04). Conclusion: This study highlights that growth failure is common in HLHS patients, despite active intervention through an IMP program. These patients appear to have significantly worse transplant-free survival rates compared to their counterparts. Pre-interstage risk factors including use of opioids may need to be addressed to assist adequate somatic growth during interstage.utf-8</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> KaitlynBates </div> <div class="author-name"> JosephNGraziano </div> <div class="author-name"> Deepti PBhat </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/08/09/71a29fc5e696b664269e5e9a3b896cd3.png" data-lightbox="image-4" data-title=""><img src="/uploads/2024/08/09/71a29fc5e696b664269e5e9a3b896cd3.png" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Research Highlight</h4> <span>19 September 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/282">Tumour Necrosis Factor Receptor-Associated Protein 1 (TRAP1): A Pivotal Regulator of Smooth Muscle Cell Senescence and Atherosclerosis through Metabolic Reprogramming</a> </h3> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> Chang Ma </div> <div class="author-name"> WenchengZhang </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/09/19/100291a267a701bde11d3cf5cb0f6fc7.jpg" data-lightbox="image-5" data-title=""><img src="/uploads/2024/09/19/100291a267a701bde11d3cf5cb0f6fc7.jpg" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Article</h4> <span>02 September 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/268">Risk Factors for Adverse Outcomes Following Surgical Repair of Simple Coarctation in Early Infancy: A Ten-Year Single Center Review</a> </h3> <p class="article-abseract clamp"> Background: Coarctation of the aorta is a frequently diagnosed congenital heart defect and often requires surgical repair in early infancy. Infants born with this condition remain at risk for post-operative morbidity and reintervention within the first year of life. Methods: A single-center, retrospective chart review was performed. The protocol was approved by the Institutional Review Board (IRB-21-156, 14 August 2021). A 10-year review from January 2010 to December 2020 identified all children diagnosed with coarctation of the aorta or arch hypoplasia; without any associated major congenital cardiac pathology (i.e., simple coarctation). Reintervention-free-survival at one year for all infants who underwent surgical repair was assessed. Patient characteristics for those who did and did not experience significant adverse event (SAE) in the postoperative period were obtained and compared. Results: A total of 105 patients diagnosed with isolated coarctation of the aorta or arch hypoplasia and who underwent surgical repair were identified. Of these, 11 patients (10%) experienced a SAE (i.e., vocal cord palsy, diaphragm palsy, chylothorax, stroke/neurological complication, need for reintubation or tracheostomy, necrotizing enterocolitis, major bleeding or thrombotic vascular complication, or reintervention) in the post-operative period. Patients who experienced a SAE were more likely to have a prenatal diagnosis of coarctation of the aorta (<i>p</i> = 0.03), a known genetic anomaly (<i>p</i> = 0.0001), or had undergone a median sternotomy approach/complex arch repair (i.e., requiring patching of the aorta) (<i>p</i> = 0.0001). Genetic anomaly (mainly Turner syndrome) was the only independent predictor of SAE in multivariate analysis (OR = 6.7) Follow up data at one year was available for 79 patients, with only 6 patients requiring reintervention before 1 year of age. Conclusions: Overall, infants who undergo surgical repair of simple coarctation of aorta have an excellent chance of reintervention-free-survival at one year post intervention. Those with a known genetic anomaly or requiring median sternotomy approach appear to have a higher risk for a SAE in the postoperative period.utf-8</p> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> ChristinaL.Benjamin </div> <div class="author-name"> RooseveltBryant III </div> <div class="author-name"> DeeptiP.Bhat </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/09/02/cb93cb1083b6d5a0b0ee5b5f772282bc.png" data-lightbox="image-6" data-title=""><img src="/uploads/2024/09/02/cb93cb1083b6d5a0b0ee5b5f772282bc.png" class=""></a> </div> </div> </div> <div class="d-flex article-box pt-3 pb-3"> <div class="sc-width-200 pr-3"> <h4>Research Highlight</h4> <span>27 September 2024</span> </div> <div class="sc-flex-value1 d-flex flex-wrap"> <div> <h3 class="article-title"> <a class="anchor" href="/article/pii/289">The Response of Vascular Endothelial Cells Post-Stroke and Its Role in Accelerating Atherosclerosis Progression</a> </h3> </div> <div class="authors-list align-self-end"> <i class="fal fa-user"></i> <div class="author-name"> KanLi </div> <div class="author-name"> ChenghuGuo </div> <div class="author-name"> ShutingYu </div> <div class="author-name"> ZekunXu </div> <div class="author-name"> MengZhang </div> </div> </div> <div class="article-img"> <div class="img-thumbnail"> <a href="/uploads/2024/09/27/50b13f90226c77bc88f0ef948826b1f4.png" data-lightbox="image-7" data-title=""><img src="/uploads/2024/09/27/50b13f90226c77bc88f0ef948826b1f4.png" class=""></a> </div> </div> </div> </div> </div> </div> </section> <section id="recent-posts-4" class="widget widget_recent_entries news-card mb-2"> <div class="my-body-container padding0"> <div class="section-heading"> <h3 class="section-title"> News </h3> </div> <ul class="d-flex align-content-around flex-wrap news-list row row-cols-1 row-cols-xl-4 row-cols-lg-3 row-cols-md-2 row-cols-sm-1 mt-3 ml-n2 mr-n2"> <li class="col mb-3 pl-2 pr-2 pb-3 d-flex flex-wrap"> <div> <div class="img"> <a href="/news/4th-cme-cardiologists-conference"> <img src="/uploads/2024/06/03/1717400707o1bm.png" alt="4th CME Cardiologists Conference" /> </a> </div> <div class="uk-card-title"> <a class="anchor" href="/news/4th-cme-cardiologists-conference">4th CME Cardiologists Conference</a> </div> </div> <div class="news-date align-self-end">5-6 May 2025丨 Istanbul, Turkey</div> </li> <li class="col mb-3 pl-2 pr-2 pb-3 d-flex flex-wrap"> <div> <div class="img"> <a href="/news/iii-cme-heartcare-and-cardiovascular-medicine-conference"> <img src="/uploads/2024/06/03/1717400099p333.png" alt="III CME Heartcare and Cardiovascular Medicine Conference" /> </a> </div> <div class="uk-card-title"> <a class="anchor" href="/news/iii-cme-heartcare-and-cardiovascular-medicine-conference">III CME Heartcare and Cardiovascular Medicine Conference</a> </div> </div> <div class="news-date align-self-end">28-29 October 2024 丨 London, UK</div> </li> <li class="col mb-3 pl-2 pr-2 pb-3 d-flex flex-wrap"> <div> <div class="img"> <a href="/news/5th-edition-of-cardiology-world-conference"> <img src="/uploads/2024/03/26/1711422818bpvg.jpg" alt="5th Edition of Cardiology World Conference" /> </a> </div> <div class="uk-card-title"> <a class="anchor" href="/news/5th-edition-of-cardiology-world-conference">5th Edition of Cardiology World Conference</a> </div> </div> <div class="news-date align-self-end">5-7 September 2024 丨 Spain</div> </li> <li class="col mb-3 pl-2 pr-2 pb-3 d-flex flex-wrap"> <div> <div class="img"> <a href="/news/2nd-edition-of-international-heart-congress"> <img src="/uploads/2024/03/26/17114224190lb2.png" alt="2nd Edition of International Heart Congress" /> </a> </div> <div class="uk-card-title"> <a class="anchor" href="/news/2nd-edition-of-international-heart-congress">2nd Edition of International Heart Congress</a> </div> </div> <div class="news-date align-self-end">20-22 June 2024 丨 France</div> </li> <li class="col mb-3 pl-2 pr-2 pb-3 d-flex flex-wrap"> <div> <div class="img"> <a href="/news/57th-annual-meeting-of-the-association-for-european-paediatric-and-congenital-cardiology"> <img src="/uploads/2024/04/25/1714022574txbd.jpg" alt="57th Annual Meeting of the Association for European Paediatric and Congenital Cardiology" /> </a> </div> <div class="uk-card-title"> <a class="anchor" href="/news/57th-annual-meeting-of-the-association-for-european-paediatric-and-congenital-cardiology">57th Annual Meeting of the Association for European Paediatric and Congenital Cardiology</a> </div> </div> <div class="news-date align-self-end">8-11 May丨Portugal</div> </li> <li class="col mb-3 pl-2 pr-2 pb-3 d-flex flex-wrap"> <div> <div class="img"> <a href="/news/33rd-european-meeting-on-hypertension-and-cardiovascular-protection"> <img src="/uploads/2024/04/25/17140227236obn.jpg" alt="33rd European Meeting on Hypertension and Cardiovascular Protection" /> </a> </div> <div class="uk-card-title"> <a class="anchor" href="/news/33rd-european-meeting-on-hypertension-and-cardiovascular-protection">33rd European Meeting on Hypertension and Cardiovascular Protection</a> </div> </div> <div class="news-date align-self-end">31 May - 3 June 2024丨Germany</div> </li> <li class="col mb-3 pl-2 pr-2 pb-3 d-flex flex-wrap"> <div> <div class="img"> <a href="/news/22nd-annual-world-congress-on-insulin-resistance-diabetes-amp-cardiovascular-disease-wcirdc-"> <img src="/uploads/2024/02/29/1709187082vof7.png" alt="22nd Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)" /> </a> </div> <div class="uk-card-title"> <a class="anchor" href="/news/22nd-annual-world-congress-on-insulin-resistance-diabetes-amp-cardiovascular-disease-wcirdc-">22nd Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)</a> </div> </div> <div class="news-date align-self-end">12-14 December 2024丨USA</div> </li> <li class="col mb-3 pl-2 pr-2 pb-3 d-flex flex-wrap"> <div> <div class="img"> <a href="/news/8th-heart-in-diabetes-cme-conference"> <img src="/uploads/2024/02/29/1709186577zimd.png" alt="8th Heart in Diabetes CME Conference" /> </a> </div> <div class="uk-card-title"> <a class="anchor" href="/news/8th-heart-in-diabetes-cme-conference">8th Heart in Diabetes CME Conference</a> </div> </div> <div class="news-date align-self-end">7-9 June 2024丨USA</div> </li> <div class="white-border"></div> </ul> </div> </section> <script> $(function () { /**/ $('.article-img > img').click(function () { var img = $(this).attr('src'); event.preventDefault(); lightbox.close(); }); /**/ $(window).scroll(function(){ var scrollTop = $(this).scrollTop(), column = $('.book-column'), columnTop = $('.avatar-news-item').offset().top; scrollTop > columnTop ? column.addClass('fixed') : column.removeClass('fixed'); }) /**/ $('.s-btn-close').click(function () { $('.form-search input').val(''); $('.form-search').submit(); }); search_txt=""; if(search_txt){ hightText(search_txt,$('#myTabContent')); } $('select[name=issues]').change(function(){ $('input[name=issues]').val($(this).val()); $('.form-search').submit(); }); //高亮匹配项方法 function hightText(inputVal,findItem){ var searchTerm = (typeof inputVal === 'string') ? inputVal:inputVal.val(); var regex = new RegExp(searchTerm, 'gi'); // 遍历所有节点并高亮匹配项 function highlightText(node) { if (node.nodeType === 3) { // Node.TEXT_NODE var match = node.data.match(regex); if (match) { var highlight = document.createElement('mark'); var words = node.data.replace(regex, function(matched) { return '<mark>' + matched + '</mark>'; }); highlight.innerHTML = words; var frag = document.createDocumentFragment(); while (highlight.firstChild) { frag.appendChild(highlight.firstChild); } while (frag.firstChild) { node.parentNode.insertBefore(frag.firstChild, node); } node.parentNode.removeChild(node); } } else if ((node.nodeType === 1) && (node.nodeName.toLowerCase() !== 'script') && (node.nodeName.toLowerCase() !== 'style')) { // Node.ELEMENT_NODE $(node).contents().each(function() { highlightText(this); }); } } highlightText(findItem[0]); } }) </script>  <footer class="mt-1"> <div class="my-body-container pt-4 pb-4"> <div class="fotter-top"> <div> <div class="item-text"> <h3>About</h3> <ul> <li> <a href="/About_SCIEPublish" title="About SClEPublish">About SClEPublish</a> </li> <li> <a href="/Management_Team" title="Management Team">Management Team</a> </li> <li> <a href="/Careers" title="Careers">Careers</a> </li> <li> <a href="/Contact" title="Contact">Contact</a> </li> </ul> </div> <div class="item-text"> <h3>Policies</h3> <ul> <li> <a href="/Peer_Review_Policy" title="Peer Review Policy">Peer Review Policy</a> </li> <li> <a href="/Open_Access_Policy" title="Open Access Policy">Open Access Policy</a> </li> <li> <a href="/Licensing_and_Copyright" title="Licensing and Copyright">Licensing and Copyright</a> </li> <li> <a href="/Editorial_Policy" title="Editorial Policy">Editorial Policy</a> </li> <li> <a href="/Advertising_Policy" title="Advertising Policy">Advertising Policy</a> </li> </ul> </div> <div class="item-text"> <h3>Information</h3> <ul> <li> <a href="/For_Authors" title="For Authors">For Authors</a> </li> <li> <a href="/For_Reviewers" title="For Reviewers">For Reviewers</a> </li> <li> <a href="/For_Editors" title="For Editors">For Editors</a> </li> </ul> </div> <div class="item-text item-text-membership"> <h3>A Member of</h3> <ul> <li class="membership-img1"> <a href="https://stm-assoc.org/" target="_blank" rel="nofollow"> <img src="/style/image/stm2024-logo.png"> </a> </li> <li class="membership-img2"> <a href="https://www.alpsp.org/" target="_blank" rel="nofollow" title=""> <img src="/style/image/alpsp-logo.png" alt=""> </a> </li>  </ul> </div> </div> <div class="item-text item-text-right"> <h3> <svg xmlns="http://www.w3.org/2000/svg" class="navbar-logo" xml:space="preserve" version="1.0" viewBox="0 0 5.08 1.933"> <path d="M1.021 1.245a.29.29 0 0 1-.211-.054l-.027-.023-.003-.003.056-.066.003.004a.3.3 0 0 0 .043.033.2.2 0 0 0 .128.027l.024-.007.019-.01a.07.07 0 0 0 .022-.032.1.1 0 0 0 0-.036l-.004-.014a.1.1 0 0 0-.016-.02.1.1 0 0 0-.027-.017L.994 1.01.919.98a.3.3 0 0 1-.076-.05.14.14 0 0 1-.034-.067.2.2 0 0 1 0-.06.13.13 0 0 1 .027-.056.2.2 0 0 1 .049-.041A.2.2 0 0 1 .95.683a.3.3 0 0 1 .07-.001.2.2 0 0 1 .06.017.3.3 0 0 1 .075.05l.003.003-.05.061L1.103.81a.2.2 0 0 0-.053-.034.2.2 0 0 0-.063-.013.1.1 0 0 0-.046.008L.925.78a.06.06 0 0 0-.023.047l.001.015.006.012a.1.1 0 0 0 .018.02.1.1 0 0 0 .027.017L.97.899l.016.006.074.032a.3.3 0 0 1 .058.033.14.14 0 0 1 .051.08.2.2 0 0 1 0 .07.15.15 0 0 1-.048.081.2.2 0 0 1-.062.035zm.527-.002a.24.24 0 0 1-.1 0 .23.23 0 0 1-.125-.069.2.2 0 0 1-.051-.089.3.3 0 0 1-.019-.119.4.4 0 0 1 .02-.12.3.3 0 0 1 .052-.09.23.23 0 0 1 .176-.076.3.3 0 0 1 .064.01.3.3 0 0 1 .053.025.2.2 0 0 1 .04.034l.002.003-.052.061L1.605.81A.2.2 0 0 0 1.56.776a.2.2 0 0 0-.037-.012.15.15 0 0 0-.082.013.13.13 0 0 0-.049.039l-.018.029a.2.2 0 0 0-.022.073.4.4 0 0 0 .002.104.2.2 0 0 0 .014.05.2.2 0 0 0 .023.04.14.14 0 0 0 .066.047.15.15 0 0 0 .107-.009l.028-.017.025-.023.003-.004.051.06-.002.003a.3.3 0 0 1-.076.059.2.2 0 0 1-.045.015m.314-.004h-.09V.69h.095v.549zm.485 0h-.331V.69h.328v.08H2.11v.141h.198v.082H2.11v.165h.242v.08zm.215 0h-.09V.69h.169a.4.4 0 0 1 .083.008L2.76.71l.031.016a.13.13 0 0 1 .044.053q.009.015.012.036a.22.22 0 0 1-.012.121l-.018.03a.176.176 0 0 1-.09.057.3.3 0 0 1-.084.011h-.076v.205zm.005-.472v.19h.068a.2.2 0 0 0 .056-.006.1.1 0 0 0 .038-.018.1.1 0 0 0 .022-.031.1.1 0 0 0 .007-.045l-.003-.03a.07.07 0 0 0-.028-.04L2.703.776 2.671.769 2.633.767zm.539.48a.2.2 0 0 1-.067-.003.1.1 0 0 1-.075-.07.3.3 0 0 1-.013-.09V.827h.093v.248a.3.3 0 0 0 .007.055l.008.017.012.012.016.007.02.002a.1.1 0 0 0 .033-.006.1.1 0 0 0 .03-.019.2.2 0 0 0 .03-.032V.826h.093v.413h-.078l-.006-.057a.2.2 0 0 1-.078.057zm.548-.002-.034.003-.03-.003-.029-.01A.2.2 0 0 1 3.51 1.2l-.007.039h-.075V.645h.093q0 .11-.002.219l.01-.008A.2.2 0 0 1 3.59.823a.2.2 0 0 1 .043-.007.2.2 0 0 1 .07.015.15.15 0 0 1 .07.074.2.2 0 0 1 .022.076.4.4 0 0 1 0 .095.3.3 0 0 1-.029.082.2.2 0 0 1-.079.075zm-.07-.077a.1.1 0 0 0 .046-.002.1.1 0 0 0 .043-.032l.015-.028a.2.2 0 0 0 .01-.036.3.3 0 0 0-.006-.114A.1.1 0 0 0 3.68.93.07.07 0 0 0 3.64.9.1.1 0 0 0 3.59.899l-.023.008-.023.015-.023.02v.193a.2.2 0 0 0 .043.027zm.424.08h-.015a.1.1 0 0 1-.051-.013l-.017-.016-.011-.022-.007-.026-.002-.031V.645h.093v.5L4 1.16l.003.004.003.003.008.002h.008l.005-.001h.004l.013.071-.004.002-.009.002zm.22-.01H4.14V.827h.093v.413zm-.026-.48L4.187.76q-.009 0-.016-.002L4.157.753a.05.05 0 0 1-.02-.02.1.1 0 0 1-.008-.027L4.13.69a.05.05 0 0 1 .027-.032L4.17.653a.07.07 0 0 1 .045.005.05.05 0 0 1 .03.048.1.1 0 0 1-.009.028.1.1 0 0 1-.02.019zm.315.488a.25.25 0 0 1-.19-.054l-.004-.003.045-.062.004.003a.3.3 0 0 0 .053.034.13.13 0 0 0 .058.012l.022-.002.016-.005.013-.008.009-.01a.05.05 0 0 0 .007-.025q0-.006-.002-.012l-.005-.01-.008-.009-.011-.008-.028-.014-.016-.006-.017-.007a.4.4 0 0 1-.079-.041.1.1 0 0 1-.028-.034L4.348.964 4.345.939a.12.12 0 0 1 .023-.07.1.1 0 0 1 .038-.033A.2.2 0 0 1 4.46.82a.2.2 0 0 1 .13.022l.037.024.003.003-.045.059-.003-.003A.2.2 0 0 0 4.54.9a.1.1 0 0 0-.065-.008.1.1 0 0 0-.027.012l-.007.01a.04.04 0 0 0-.007.022q0 .006.002.01l.005.01a.1.1 0 0 0 .017.015l.027.013.016.006.016.006.063.028.019.013a.1.1 0 0 1 .029.035l.008.023a.13.13 0 0 1-.008.077.1.1 0 0 1-.03.04.14.14 0 0 1-.05.027zm.307-.007h-.088V.645h.092q0 .115-.002.229a.3.3 0 0 1 .05-.038.2.2 0 0 1 .048-.017.2.2 0 0 1 .068.002.1.1 0 0 1 .057.038q.01.014.018.033A.314.314 0 0 1 5.08.98v.258h-.093V.99L4.985.96 4.98.936 4.97.92 4.96.907 4.943.9a.1.1 0 0 0-.037 0 .1.1 0 0 0-.03.011l-.016.01-.032.03v.288z" /> <path d="M1.844 1.377a.97.97 0 0 1-.878.563A.963.963 0 0 1 0 .974.964.964 0 0 1 .966.007a.96.96 0 0 1 .865.536l-.048.024A.92.92 0 0 0 .966.062a.91.91 0 0 0-.912.912.91.91 0 0 0 .912.912.91.91 0 0 0 .83-.532z" class="logo-circle" /> </svg> </h3> <div class="text-share"> <a href="https://x.com/SCIEPublish" class="share-btn twitter-btn" title="Share on Twitter" target="_blank"> <svg t="1713929395475" class="icon" width="32" height="32" viewBox="0 0 1399 1024" fill="#000000" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="8742"> <path d="M282.021569 119.281213l323.998199 433.216256-326.044203 352.222995h73.379441l285.451142-308.376452 230.636674 308.376452h249.713149l-342.227762-457.583832 303.479459-327.855419h-73.379441l-262.886398 284.008876-212.407111-284.008876h-249.713149z m107.909957 54.051408h114.71879l506.578928 677.328049h-114.718791l-506.578927-677.328049z" p-id="8743"></path> </svg> </a> <a href="" class="share-btn LinkedIn-btn" id="email-LinkedIn-btn" title="Share on LinkedIn" target="_blank"> <svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" fill="#000000" class="bi bi-linkedin" viewBox="0 0 16 16"> <path d="M0 1.146C0 .513.526 0 1.175 0h13.65C15.474 0 16 .513 16 1.146v13.708c0 .633-.526 1.146-1.175 1.146H1.175C.526 16 0 15.487 0 14.854V1.146zm4.943 12.248V6.169H2.542v7.225h2.401zm-1.2-8.212c.837 0 1.358-.554 1.358-1.248-.015-.709-.52-1.248-1.342-1.248-.822 0-1.359.54-1.359 1.248 0 .694.521 1.248 1.327 1.248h.016zm4.908 8.212V9.359c0-.216.016-.432.08-.586.173-.431.568-.878 1.232-.878.869 0 1.216.662 1.216 1.634v3.865h2.401V9.25c0-2.22-1.184-3.252-2.764-3.252-1.274 0-1.845.7-2.165 1.193v.025h-.016a5.54 5.54 0 0 1 .016-.025V6.169h-2.4c.03.678 0 7.225 0 7.225h2.4z"/> </svg> </a> <a href="javaScript:void(0)" class="share-btn wechat-btn" id="wechat-share-btn"> <svg xmlns="http://www.w3.org/2000/svg" width="26" height="26" fill="#000000" class="bi bi-wechat" viewBox="0 0 16 16"> <path d="M11.176 14.429c-2.665 0-4.826-1.8-4.826-4.018 0-2.22 2.159-4.02 4.824-4.02S16 8.191 16 10.411c0 1.21-.65 2.301-1.666 3.036a.324.324 0 0 0-.12.366l.218.81a.616.616 0 0 1 .029.117.166.166 0 0 1-.162.162.177.177 0 0 1-.092-.03l-1.057-.61a.519.519 0 0 0-.256-.074.509.509 0 0 0-.142.021 5.668 5.668 0 0 1-1.576.22ZM9.064 9.542a.647.647 0 1 0 .557-1 .645.645 0 0 0-.646.647.615.615 0 0 0 .09.353Zm3.232.001a.646.646 0 1 0 .546-1 .645.645 0 0 0-.644.644.627.627 0 0 0 .098.356Z"/> <path d="M0 6.826c0 1.455.781 2.765 2.001 3.656a.385.385 0 0 1 .143.439l-.161.6-.1.373a.499.499 0 0 0-.032.14.192.192 0 0 0 .193.193c.039 0 .077-.01.111-.029l1.268-.733a.622.622 0 0 1 .308-.088c.058 0 .116.009.171.025a6.83 6.83 0 0 0 1.625.26 4.45 4.45 0 0 1-.177-1.251c0-2.936 2.785-5.02 5.824-5.02.05 0 .1 0 .15.002C10.587 3.429 8.392 2 5.796 2 2.596 2 0 4.16 0 6.826Zm4.632-1.555a.77.77 0 1 1-1.54 0 .77.77 0 0 1 1.54 0Zm3.875 0a.77.77 0 1 1-1.54 0 .77.77 0 0 1 1.54 0Z"/> </svg> <div class="cord"> <div class="img"> <img src="/style/image/wechat.jpg" alt="SCIEPublish wechat" /> </div> </div> </a> <a href="mailto:office@sciepublish.org" class="share-btn email-btn" id="email-share-btn" title="Share on Email" target="_blank"> <svg xmlns="http://www.w3.org/2000/svg" width="26" height="26" fill="#000000" class="bi bi-envelope-fill" viewBox="0 0 16 16"> <path d="M.05 3.555A2 2 0 0 1 2 2h12a2 2 0 0 1 1.95 1.555L8 8.414.05 3.555ZM0 4.697v7.104l5.803-3.558L0 4.697ZM6.761 8.83l-6.57 4.027A2 2 0 0 0 2 14h12a2 2 0 0 0 1.808-1.144l-6.57-4.027L8 9.586l-1.239-.757Zm3.436-.586L16 11.801V4.697l-5.803 3.546Z"/> </svg> </a> </div> </div> </div> <div class="copyright-box mt-4 mb-0 pt-3 pb-0"> <p class="text-left">Copyright © 2021-2024 SCIE Publishing Ltd. unless otherwise stated.</p> <p class="text-right"> <a href="/Privacy" title="Privacy">Privacy</a>  <a href="/Terms_of_Use" title="Terms of Use">Terms of Use</a> </p> </div> </div> </footer>  <div class="back-top"> <div class="d-flex justify-content-center align-items-center flex-wrap"> <svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" fill="currentColor" class="bi bi-chevron-up" viewBox="0 0 16 16"> <path fill-rule="evenodd" d="M7.646 4.646a.5.5 0 0 1 .708 0l6 6a.5.5 0 0 1-.708.708L8 5.707l-5.646 5.647a.5.5 0 0 1-.708-.708l6-6z"/> </svg> <span>TOP</span> </div> </div>  <div class="toast-container"> <div class="toast" id="liveToast" role="alert" data-delay="3000" aria-live="assertive" aria-atomic="true"> <div class="toast-header"> <strong class="mr-auto">Message</strong> <button type="button" class="ml-2 mb-1 close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">×</span> </button> </div> <div class="toast-body"> </div> </div> </div> <script> $(function () { $('.js-navbar-toggle').on('click', function () { $('header nav').toggleClass('nav-search-active'); }); var windowHeight = $(window).height(), header = $('header'), backTop = $('.back-top'); $(window).scroll(function(){ var scrollTop = $(this).scrollTop(); scrollTop > 0 ? header.addClass('fixed') : header.removeClass('fixed'); scrollTop > windowHeight ? backTop.addClass('fixed') : backTop.removeClass('fixed'); }) backTop.click(function(){ $("body,html").animate({scrollTop:0},300); }) $(".article-abseract.clamp").each(function () { $(this).click(function () { $(this).toggleClass("clamp-open"); }); }); //初始化select $('select.select-mania').selectMania(); }) $('.logout').click(function () { $.get('/index/user/login_out', function (res) { if (res.err == 0) { window.location.href = res.data layer.msg('exit successfully!') } else { layer.msg('Exit failed!') } }) }) </script> </body> </html>

CINXE.COM

Cardiovascular Science - Journal - SCIEPublish